U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.26_40dup (p.4_8NRQPR[3]) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 25, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000218325.7

Allele description [Variation Report for NM_000465.4(BARD1):c.26_40dup (p.4_8NRQPR[3])]

NM_000465.4(BARD1):c.26_40dup (p.4_8NRQPR[3])

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.26_40dup (p.4_8NRQPR[3])
HGVS:
  • NC_000002.12:g.214809543_214809557dup
  • NG_012047.3:g.5168_5182dup
  • NM_000465.4:c.26_40dupMANE SELECT
  • NM_001282543.2:c.26_40dup
  • NM_001282545.2:c.26_40dup
  • NM_001282548.2:c.26_40dup
  • NM_001282549.2:c.26_40dup
  • NP_000456.2:p.4_8NRQPR[3]
  • NP_001269472.1:p.4_8NRQPR[3]
  • NP_001269474.1:p.4_8NRQPR[3]
  • NP_001269477.1:p.4_8NRQPR[3]
  • NP_001269478.1:p.4_8NRQPR[3]
  • LRG_297t1:c.26_40dup
  • LRG_297:g.5168_5182dup
  • LRG_297p1:p.4_8NRQPR[3]
  • NC_000002.11:g.215674253_215674254insTCCTCGGCTGCCGGT
  • NC_000002.11:g.215674267_215674281dup
  • NG_012047.2:g.5161_5175dup
  • NM_000465.2:c.26_40dupACCGGCAGCCGAGGA
  • NM_000465.3:c.26_40dupACCGGCAGCCGAGGA
  • NR_104212.2:n.140_154dup
  • NR_104215.2:n.140_154dup
  • NR_104216.2:n.140_154dup
Links:
dbSNP: rs587781979
NCBI 1000 Genomes Browser:
rs587781979
Molecular consequence:
  • NM_000465.4:c.26_40dup - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001282543.2:c.26_40dup - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001282545.2:c.26_40dup - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001282548.2:c.26_40dup - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001282549.2:c.26_40dup - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NR_104212.2:n.140_154dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.140_154dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104216.2:n.140_154dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000273310Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(May 25, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV000273310.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.26_40dup15 variant (also known as p.N9_R13dup), located in coding exon 1 of the BARD1 gene, results from an in-frame duplication of 15 nucleotides at nucleotide positions 26 to 40. This results in the duplication of 5 extra residues (NRQPR) between codons 9 and 13. This amino acid region is not well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024